BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1106105)

  • 1. Clinical trial of ORAP in schizophrenia.
    Mrna B; Klima V; Koupil M; Komenda S
    Act Nerv Super (Praha); 1975 Sep; 17(3):204-5. PubMed ID: 1106105
    [No Abstract]   [Full Text] [Related]  

  • 2. Results obtained with Orap in the therapy of neuropsychiatric outpatients.
    Perényi G; Várkonyi B+VARKONYI B
    Ther Hung; 1974; 22(2):65-8. PubMed ID: 4608508
    [No Abstract]   [Full Text] [Related]  

  • 3. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
    Denijs EL; Vereecken JL
    Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
    [No Abstract]   [Full Text] [Related]  

  • 4. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract]   [Full Text] [Related]  

  • 6. Pimozide (Orap) in patients with pseudo-neurotic behaviour.
    Tanghe AJ; Boom AJ; Leuridan P; Jonckheere L; Bruynooghe F
    Acta Psychiatr Belg; 1977; 77(2):294-305. PubMed ID: 906889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
    Vergara L; Amin MM; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients.
    Kolivakis T; Azim H; Kingstone E
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):998-1004. PubMed ID: 4214674
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance and advantages of Orap in the ambulatory care of schizophrenic psychoses].
    König L; Lange E
    Psychiatr Neurol Med Psychol (Leipz); 1976 Feb; 28(2):106-13. PubMed ID: 940884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
    Kudo Y
    Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
    [No Abstract]   [Full Text] [Related]  

  • 11. Pimozide (R6238) in chronic schizophrenia: double blind trial.
    Gowardman M; Barrer B; Brown RA
    N Z Med J; 1973 Dec; 78(504):487-91. PubMed ID: 4591853
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pimozide and piportil in the treatment of chronic schizophrenia (preliminary communication)].
    Masiak M; Majczak A; Hascewicz-Rzecka M; Kowalczyk A
    Psychiatr Pol; 1976; 10(6):655-60. PubMed ID: 13443
    [No Abstract]   [Full Text] [Related]  

  • 13. A multicenter multidimensional study of some new longacting neuroleptic drugs.
    Acta Psychiatr Scand Suppl; 1974; 249():1-134. PubMed ID: 4608507
    [No Abstract]   [Full Text] [Related]  

  • 14. Pimozide treatment of the negative schizophrenic syndrome: an open trial.
    Feinberg SS; Kay SR; Elijovich LR; Fiszbein A; Opler LA
    J Clin Psychiatry; 1988 Jun; 49(6):235-8. PubMed ID: 3288615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
    Wilson LG; Roberts RW; Gerber CJ; Johnson MH
    J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and statistical evaluation of neuroleptic pimozide].
    Glatzel J
    Int Pharmacopsychiatry; 1971; 6(1):60-6. PubMed ID: 5163169
    [No Abstract]   [Full Text] [Related]  

  • 18. Pimozide: an effective, once daily oral therapy for schizophrenia.
    Van Wyk AJ; Grové JJ
    S Afr Med J; 1972 Apr; 46(17):515-7. PubMed ID: 4570652
    [No Abstract]   [Full Text] [Related]  

  • 19. The observer interaction variable in evaluation of socialising properties of pimozide (Orap).
    McInnes EJ; Walker F; Snelling E
    N Z Med J; 1978 Mar; 87(607):170-2. PubMed ID: 349428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot evaluation of Orap (pimozide, R 6238) in child psychiatry.
    Pangalila-Ratulangi EA
    Psychiatr Neurol Neurochir; 1973; 76(1):17-27. PubMed ID: 4572950
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.